Autonomous Artificial Intelligence Agents for Clinical Decision Making in Oncology
Multimodal artificial intelligence (AI) systems have the potential to enhance clinical decision-making by interpreting various types of medical data. However, the effectiveness of these models across all medical fields is uncertain. Each discipline presents unique challenges that need to be addressed for optimal performance. This complexity is further increased when attempting to integrate different fields into a single model. Here, we introduce an alternative approach to multimodal medical AI that utilizes the generalist capabilities of a large language model (LLM) as a central reasoning engine. This engine autonomously coordinates and deploys a set of specialized medical AI tools. These tools include text, radiology and histopathology image interpretation, genomic data processing, web searches, and document retrieval from medical guidelines. We validate our system across a series of clinical oncology scenarios that closely resemble typical patient care workflows. We show that the system has a high capability in employing appropriate tools (97%), drawing correct conclusions (93.6%), and providing complete (94%), and helpful (89.2%) recommendations for individual patient cases while consistently referencing relevant literature (82.5%) upon instruction. This work provides evidence that LLMs can effectively plan and execute domain-specific models to retrieve or synthesize new information when used as autonomous agents. This enables them to function as specialist, patient-tailored clinical assistants. It also simplifies regulatory compliance by allowing each component tool to be individually validated and approved. We believe, that our work can serve as a proof-of-concept for more advanced LLM-agents in the medical domain.
Code (0)
등록된 구현이 없습니다.
Tasks
Decision MakingLanguage ModellingLarge Language ModelMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Bio AI Agent: A Multi-Agent Artificial Intelligence System for Autonomous CAR-T Cell Therapy Development with Integrated Target Discovery, Toxicity Prediction, and Rational Molecular Design
Chimeric antigen receptor T-cell (CAR-T) therapy represents a paradigm shift in cancer treatment, yet development timelines of 8-12 years and clinical attrition rates exceeding 40-60% highlight critical inefficiencies in…
Can Artificial Intelligence Embody Moral Values?
The neutrality thesis holds that technology cannot be laden with values. This long-standing view has faced critiques, but much of the argumentation against neutrality has focused on traditional, non-smart technologies li…
FairnessAgentic Discovery: Closing the Loop with Cooperative Agents
As data-driven methods, artificial intelligence (AI), and automated workflows accelerate scientific tasks, we see the rate of discovery increasingly limited by human decision-making tasks such as setting objectives, gene…
Artificial Intelligence-based Clinical Decision Support for COVID-19 -- Where Art Thou?
The COVID-19 crisis has brought about new clinical questions, new workflows, and accelerated distributed healthcare needs. While artificial intelligence (AI)-based clinical decision support seemed to have matured, the ap…
An Approach to Joint Hybrid Decision Making between Humans and Artificial Intelligence
Due to the progress in artificial intelligence, it is important to understand how capable artificial agents should be used when interacting with humans, since high level authority and responsibility often remain with the…
Decision Making